Skip to main content

How to Make Bispecific Antibodies

  • Protocol
Diagnostic and Therapeutic Antibodies

Part of the book series: Methods in Molecular Medicine ((MIMM,volume 40))

Abstract

This protocol describes the production of bispecific F(ab’)2 antibody derivatives (BsAbs) by the linking of two Fab’ fragments via their hinge region SH groups using the bifunctional crosslinker o-phenylenedimaleimide (o-PDM) as described by Glennie et al. (1,2). The procedure is illustrated in Fig. 1. The first step is to obtain F(ab’)2 from the two parent IgG antibodies. Methods for digestion of IgG to F(ab’)2 are described in Chapter 25. Fab’ fragments are then prepared from the two F(ab’)2 species by reduction with thiol, thus exposing free SH groups at the hinge region (three SH-groups for mouse IgG1 and IgG2a antibodies) (seeNote 1). One of the Fab’ species (Fab’-A) is selected for alkylation with o-PDM. Because o-PDM has a strong tendency to crosslink adjacent intramolecular SH-groups, two of the three hinge SH-groups will probably be linked together, leaving a single reactive maleimide group available for conjugation (Fig. 1; seeNote 2). Excess o-PDM is then removed by column chromatography, and the Fab’-A(mal) is mixed with the second reduced Fab’ (Fab’-B) under conditions favoring the crosslinking of the maleimide and SH groups. When equal amounts of the two parent Fab’ species are used, the major product is bispecific F(ab’)2, resulting from the reaction of one Fab’-A(mal) with one of the SH groups at the hinge of Fab’-B. Increasing the proportion of Fab’-A(mal) in the reaction mixture results in a significant amount of F(ab’)3 product by the reaction of two molecules of Fab’-A(mal) with two free SH-groups at the hinge of a single Fab’-B molecule (seeNote 3). The remaining free SH groups on Fab’-B are alkylated, and the F(ab’)2 bispecific antibody product (Fab’-A x Fab’-B) is separated by gel filtration chromatography. Each stage of the procedure is checked by HPLC.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

Similar content being viewed by others

References

  1. Glennie, M. J., McBride, H. M., Worth, A. T., and Stevenson, G. T. (1987) Preparation and performance of bispecific F(ab’y)2 antibody containing thioether-linked Fab’y fragments. J. Immunol.139, 2367–2375.

    CAS  PubMed  Google Scholar 

  2. Glennie, M. J., Tutt, A. L., and Greenman, J. (1993) Preparation of multispecific F(ab’)2 and F(ab’)3 antibody derivatives, in Tumour Immunobiology, A Practical Approach (Gallagher, G., Rees, R. C., and Reynolds, C. W., eds.), Oxford University Press, Oxford, UK, pp. 225–244.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Humana Press Inc.

About this protocol

Cite this protocol

French, R.R. (2000). How to Make Bispecific Antibodies. In: George, A.J.T., Urch, C.E. (eds) Diagnostic and Therapeutic Antibodies. Methods in Molecular Medicine, vol 40. Humana, Totowa, NJ. https://doi.org/10.1385/1-59259-076-4:333

Download citation

  • DOI: https://doi.org/10.1385/1-59259-076-4:333

  • Publisher Name: Humana, Totowa, NJ

  • Print ISBN: 978-0-89603-798-4

  • Online ISBN: 978-1-59259-076-6

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics